---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-23-008091"
form_type: "8-K"
ticker: "ZIVO"
cik: "0001101026"
company_name: "Zivo Bioscience, Inc."
filed_at: "2023-06-16T23:59:59+00:00"
generated_at: "2026-06-13T22:18:10.138425+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Zivo Bioscience stockholders elect Maggiore, ratify BDO, approve exec compensation

## Summary
- Christopher D. Maggiore elected to board with 3,050,053 votes for, 393,297 withheld; 2,704,419 broker non-votes.
- BDO USA, LLP ratified as auditor for FY2023: 5,982,232 for, 164,958 against, 579 abstain.
- Advisory vote on executive compensation approved: 3,252,348 for, 186,946 against, 4,056 abstain.

## SEC filing metadata
- accession: 0001654954-23-008091
- form_type: 8-K
- ticker: ZIVO
- cik: 0001101026
- company_name: Zivo Bioscience, Inc.
- filed_at: 2023-06-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1101026/000165495423008091/0001654954-23-008091-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1101026/000165495423008091/zivo_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-23-008091
- JSON: https://secwatch.observer/filing/0001654954-23-008091.json
- Plain text: https://secwatch.observer/filing/0001654954-23-008091.txt

## Key facts
- Shareholder Votes
  Zivo Bioscience, Inc. shareholders approved Election of one director to serve a three-year term until the 2026 annual meeting of stockholders at the 2023-06-12 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-06-12
  source text: Proposal 1—Election of Directors Nominee Votes For Votes Withheld Broker Non-Votes Christopher D. Maggiore 3,050,053 393,297 2,704,419
  evidence_url: https://www.sec.gov/Archives/edgar/data/1101026/000165495423008091/0001654954-23-008091-index.htm
- Shareholder Votes
  Zivo Bioscience, Inc. shareholders approved Approval (on an advisory basis) of the compensation of the Company's named executive officers at the 2023-06-12 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2023-06-12
  source text: Proposal 3 — Approval (on an advisory basis) of the compensation of the Company's named executive officers Votes For Votes Against Votes Abstain 3,252,348 186,946 4,056
  evidence_url: https://www.sec.gov/Archives/edgar/data/1101026/000165495423008091/0001654954-23-008091-index.htm
- Shareholder Votes
  Zivo Bioscience, Inc. shareholders approved Ratification of the appointment of BDO USA, LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023 at the 2023-06-12 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-06-12
  source text: Proposal 2—Ratification of Appointment of Independent Registered Public Accounting Firm Votes For Votes Against Votes Abstain 5,982,232 164,958 579
  evidence_url: https://www.sec.gov/Archives/edgar/data/1101026/000165495423008091/0001654954-23-008091-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.